J Mycol Infect.
2022 Mar;27(1):19-20. 10.17966/JMI.2022.27.1.19.
Pilomatricoma Developed After SARS-CoV-2 mRNA Vaccine Inoculation
- Affiliations
-
- 1Department of Dermatology, National Medical Center, Seoul, Korea
- KMID: 2536738
- DOI: http://doi.org/10.17966/JMI.2022.27.1.19
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers
- SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
- Anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine and associated factors in Japanese hemodialysis patients
- New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review
- A Case of Exanthematous Drug Eruption Caused by mRNA-1273 (Moderna) SARS-CoV-2 Vaccine
